BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16465169)

  • 1. Chinese biotech: the need for innovation and higher standards.
    Wong GH
    Nat Biotechnol; 2006 Feb; 24(2):221-2. PubMed ID: 16465169
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 3. France to focus on a few biotech clusters.
    Balcon E
    Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
    [No Abstract]   [Full Text] [Related]  

  • 4. Germany reattempts to spark innovation.
    Habeck M
    Nat Biotechnol; 2004 Mar; 22(3):257-8. PubMed ID: 14990939
    [No Abstract]   [Full Text] [Related]  

  • 5. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotechnology in South Africa.
    Cloete TE; Nel LH; Theron J
    Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First U.S.-Russian business venture in closed nuclear city.
    Lopatto J; Wilkes B
    Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
    [No Abstract]   [Full Text] [Related]  

  • 8. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA launches two research centers with academia.
    Fox JL
    Nat Biotechnol; 2014 Jul; 32(7):601. PubMed ID: 25004209
    [No Abstract]   [Full Text] [Related]  

  • 10. Singapore R&D and globetrotting.
    Lear MJ; Salmons B; Gunzburg WH; Dangerfield JA
    Biotechnol J; 2009 Feb; 4(2):179-85. PubMed ID: 19156748
    [No Abstract]   [Full Text] [Related]  

  • 11. International regional collaborations are paying off.
    Mitchell P
    Nat Biotechnol; 2004 Nov; 22(11):1475. PubMed ID: 15586420
    [No Abstract]   [Full Text] [Related]  

  • 12. University spin-offs: opportunity or challenge?
    Peng X
    Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
    [No Abstract]   [Full Text] [Related]  

  • 13. Superscience me!
    Nat Biotechnol; 2007 Jun; 25(6):604. PubMed ID: 17557082
    [No Abstract]   [Full Text] [Related]  

  • 14. The Netherlands innovation utilising.
    Med Device Technol; 2008 Sep; 19(5):58-9. PubMed ID: 18947153
    [No Abstract]   [Full Text] [Related]  

  • 15. Spanish wishful thinking towards biotech.
    Sheridan C
    Nat Biotechnol; 2005 Mar; 23(3):385. PubMed ID: 15841507
    [No Abstract]   [Full Text] [Related]  

  • 16. India aims to become the main bioinformatics hub.
    Jayaraman KS; Louët S
    Nat Biotechnol; 2004 Aug; 22(8):933. PubMed ID: 15286632
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of competitive intelligence in biotech startups.
    Carlucci S; Page A; Finegold D
    Nat Biotechnol; 2005 May; 23(5):525-7. PubMed ID: 15942983
    [No Abstract]   [Full Text] [Related]  

  • 18. A European biotechnology transfer platform?
    Suojanen C
    N Biotechnol; 2009 Apr; 25(4):167-8. PubMed ID: 19429530
    [No Abstract]   [Full Text] [Related]  

  • 19. China moves to reform biotech policies.
    Jia H
    Nat Biotechnol; 2004 Oct; 22(10):1197. PubMed ID: 15470442
    [No Abstract]   [Full Text] [Related]  

  • 20. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea.
    Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY
    Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.